Cargando…
Mir-34a Mimics Are Potential Therapeutic Agents for p53-Mutated and Chemo-Resistant Brain Tumour Cells
Chemotherapeutic drug resistance and relapse remains a major challenge for paediatric (medulloblastoma) and adult (glioblastoma) brain tumour treatment. Medulloblastoma tumours and cell lines with mutations in the p53 signalling pathway have been shown to be specifically insensitive to DNA damaging...
Autores principales: | Fan, Yuen Ngan, Meley, Daniel, Pizer, Barry, Sée, Violaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177398/ https://www.ncbi.nlm.nih.gov/pubmed/25250818 http://dx.doi.org/10.1371/journal.pone.0108514 |
Ejemplares similares
-
Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells
por: Cowman, Sophie, et al.
Publicado: (2019) -
Downregulation of both mismatch repair and non-homologous end-joining pathways in hypoxic brain tumour cell lines
por: Cowman, Sophie, et al.
Publicado: (2021) -
p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma
por: Meley, D, et al.
Publicado: (2010) -
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
por: Hong, David S., et al.
Publicado: (2020) -
The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents
por: Mitsiogianni, Melina, et al.
Publicado: (2019)